Wiley.com
Print this page Share

Benefit-Risk Appraisal of Medicines: A Systematic Approach to Decision-making

Filip Mussen, Sam Salek, Stuart Walker
ISBN: 978-0-470-06085-8
Hardcover
304 pages
February 2010
List Price: US $138.25
Government Price: US $95.32
Enter Quantity:   Buy
Benefit-Risk Appraisal of Medicines: A Systematic Approach to Decision-making (0470060859) cover image

Dr Sam Salek, Reader in Pharmacoepidemiology, Director - WSP Centre for Socioeconomic Research; Director - Postgraduate Course in Pharmaceutical Medicine, Cardiff University, UK.

Mr Filip Mussen, Johnson & Johnson Pharmaceuticals Research and Development, Belgium.

Prof Stuart Walker, President and Founder, International Institute for Regulatory Science, UK.

More By These Authors

Sam Salek (Editor), Andrew Edgar (Editor)
Juliet Bates, Chris Gallon, Matthew Bocci, Stuart Walker, Tom Taylor

Related Titles

More By These Authors

Converged Multimedia Networks
Pharmaceutical Ethics

General Pharmacology & Pharmaceutical Medicine

The Cancer Clock
by Sotiris Missailidis (Editor)
Nuclear Receptors in Drug Metabolism
by Wen Xie (Editor)
Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials
by Joy A. Cavagnaro (Editor)
Drug-Induced Mitochondrial Dysfunction
by James A. Dykens (Editor), Yvonne Will (Editor)
Dopamine Transporters: Chemistry, Biology, and Pharmacology
by Mark L. Trudell (Editor), Sari Izenwasser (Editor), Binghe Wang (Series Editor)
Drug Metabolism Handbook: Concepts and Applications
Cancer Stem Cells: Identification and Targets
by Sharmila A. Bapat (Editor)
Back to Top